WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

China’s drugmakers to take the stage at ASCO

It’s no secret that Akeso’s presentation will be one of the most closely watched readouts from the American Society of Clinical Oncology annual meeting this year.

Raccontata daendpoints.newsbiopharmadive.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
endpoints.newsStai leggendo1 mesi fa

China’s drugmakers to take the stage at ASCO

It’s no secret that Akeso’s presentation will be one of the most closely watched readouts from the American Society of Clinical Oncology annual meeting this year.

originale
biopharmadive.com1 mesi fa

ASCO26: 5 data snapshots ahead of the year’s biggest cancer drug meeting

Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting gave a peek at anticipated datasets from Merck, BioNTech, Eli Lilly and Moderna.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 21 maggio 2026·endpoints.news

    China’s drugmakers to take the stage at ASCO

    It’s no secret that Akeso’s presentation will be one of the most closely watched readouts from the American Society of Clinical Oncology annual meeting this year.

  2. venerdì 22 maggio 2026·biopharmadive.com

    ASCO26: 5 data snapshots ahead of the year’s biggest cancer drug meeting

    Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting gave a peek at anticipated datasets from Merck, BioNTech, Eli Lilly and Moderna.